fluorodeoxyglucose f18 has been researched along with Benign Supratentorial Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abildgaard, N; Alavi, A; Gerke, O; Holdgaard, P; Høilund-Carlsen, PF; Khosravi, M; Kim, J; Nielsen, AL; Pourhassan Shamchi, S; Raynor, WY; Revheim, ME; Taghvaei, R; Werner, TJ; Zirakchian Zadeh, M; Østergaard, B | 1 |
| Cama, A; Garrè, ML; Mascelli, S; Massollo, M; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Raso, A; Rossi, A | 1 |
| Balkay, L; Emri, M; Lengyel, Z; Molnar, P; Novak, L; Tron, L | 1 |
| Go, KG; Heesters, MA; Kamman, RL; Mooyaart, EL; Paans, AM; Pruim, J; Vaalburg, W | 1 |
| Aloj, L; Brunetti, A; Di Chiro, G; Dwyer, AJ; Fulham, MJ; Raman, R | 1 |
| De Maeght, S; Labar, D; Lambotte, L; Laterre, C; Pauwels, S; Stroobandt, G; Vander Borght, T | 1 |
| Bauer, B; Heiss, WD; Herholz, K; Pietrzyk, U; Sturm, V; Treuer, H; Voges, J; Würker, M | 1 |
| Berger, MS; Freeman, SD; Graham, MM; Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Muzi, M; O'Sullivan, F; Ojemann, GA; Spence, AM | 1 |
| Blasberg, RG; Herrmann, R; Hofer, S; Leenders, KL; Maguire, RP; Radü, EW; Roelcke, U; von Ammon, K; Vontobel, P | 1 |
| Bartenstein, P; Feldmann, HJ; Gross, MW; Molls, M; Schwaiger, M; Weber, WA | 1 |
| Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG | 1 |
| Benali, K; Bouvard, G; Chajari, MH; Chapon, F; Derlon, JM; Houtteville, JP; Khouri, S; Noël, MH; Petit-Taboué, MC | 1 |
| Meyer, PT; Mueller, HD; Sabri, O; Schreckenberger, M; Spetzger, U; Zeggel, T | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour.
Topics: Adolescent; Adult; Aged; Brain Mapping; Epilepsy; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Radiopharmaceuticals; Supratentorial Neoplasms; Temporal Lobe; Tomography, Emission-Computed | 2004 |
12 other study(ies) available for fluorodeoxyglucose f18 and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Chemistry; Cerebellum; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple Myeloma; Observer Variation; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stem Cell Transplantation; Supratentorial Neoplasms; Transplantation, Autologous | 2020 |
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Sensitivity and Specificity; Supratentorial Neoplasms | 2015 |
Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Edema; Carbon Radioisotopes; Creatine; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Phosphorylcholine; Supratentorial Neoplasms; Tomography, Emission-Computed; Tyrosine | 1995 |
Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
Topics: Adult; Aged; Anticonvulsants; Brain; Case-Control Studies; Cerebellum; Cerebral Cortex; Combined Modality Therapy; Cushing Syndrome; Deoxyglucose; Dexamethasone; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Supratentorial Neoplasms; Tomography, Emission-Computed | 1995 |
Brain tumor imaging with PET and 2-[carbon-11]thymidine.
Topics: Adolescent; Adult; Aged; Brain; Carbon Radioisotopes; Child; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Thymidine; Tomography, Emission-Computed | 1994 |
Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.
Topics: Adult; Astrocytoma; Brachytherapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Iodine Radioisotopes; Male; Methionine; Middle Aged; Supratentorial Neoplasms; Tomography, Emission-Computed | 1996 |
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Topics: Autoradiography; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Supratentorial Neoplasms; Tomography, Emission-Computed | 1998 |
Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Topics: Antineoplastic Agents, Hormonal; Blood Glucose; Brain; Dexamethasone; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Supratentorial Neoplasms; Tomography, Emission-Computed | 1998 |
The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Topics: Adult; Aged; Astrocytoma; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Supratentorial Neoplasms; Survival Analysis; Tomography, Emission-Computed | 1998 |
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.
Topics: Adult; Amino Acids; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Methionine; Oligodendroglioma; Radiopharmaceuticals; Supratentorial Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case report.
Topics: Adolescent; Fluorodeoxyglucose F18; Ganglioglioma; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuroglia; Radiopharmaceuticals; Supratentorial Neoplasms; Tomography, Emission-Computed | 2000 |